Min, Sungjin http://orcid.org/0000-0002-5041-8638
Kim, Suran
Sim, Woo-Sup http://orcid.org/0000-0001-7425-8192
Choi, Yi Sun http://orcid.org/0000-0002-4691-8875
Joo, Hyebin
Park, Jae-Hyun
Lee, Su-Jin
Kim, Hyeok http://orcid.org/0000-0001-9184-5882
Lee, Mi Jeong http://orcid.org/0000-0003-4807-9558
Jeong, Inhea http://orcid.org/0000-0003-2226-4755
Cui, Baofang
Jo, Sung-Hyun http://orcid.org/0000-0002-2854-1568
Kim, Jin-Ju
Hong, Seok Beom
Choi, Yeon-Jik
Ban, Kiwon
Kim, Yun-Gon
Park, Jang-Ung
Lee, Hyang-Ae http://orcid.org/0000-0002-0036-4555
Park, Hun-Jun http://orcid.org/0000-0001-8009-9546
Cho, Seung-Woo http://orcid.org/0000-0001-8058-332X
Article History
Received: 26 May 2023
Accepted: 13 March 2024
First Online: 22 March 2024
Competing interests
: S.-W.C., S.M., Y.S.C. and S.K. are co-inventors on a patent application (Korean Patent 10-2021-0020145, pending) related to decellularized heart-derived ECM for cardiac tissue generation and culture. S.-W.C. is a chief technology officer (CTO) of Cellartgen, Inc., Republic of Korea. The remaining authors declare no competing interests.